Amyloid anticorps (PerCP)

N° du produit ABIN2486111

Cet anticorps anti- est un anticorps Lapin Polyclonal détectant dans ELISA, IP, IHC, WB, ICC, IF et DB. Adapté pour Humain.

Aperçu rapide pour Amyloid anticorps (PerCP) (ABIN2486111)

Antigène: Amyloid

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: PerCP

Application: ELISA, Immunoprecipitation (IP), Immunohistochemistry (IHC), Western Blotting (WB), Immunocytochemistry (ICC), Immunofluorescence (IF), Dot Blot (DB)

Détail du produit

Specificité: Recognizes generic epitopes common to many amyloid fibrils and fibrillar oligomers, but not prefibrillar oligomers or natively folded proteins. Expected to detect in Mouse and Rat based on homology.

Réactivité croisée: Humain

Purification: Protein A Purified

Immunogène: Fibrils prepared from human amyloid beta 42 peptide

Information d'application

Indications d'application:

• WB (1:1000)
• IHC (1:100)
• optimal dilutions for assays should be determined by the user.

Commentaires:

A 1:1000 dilution of ABIN2486111 was sufficient for detection of amyloid fibrils on PVDF membranes using transferred fibrils by colorimetric dot blot analysis using Goat anti-rabbit IgG:HRP as the secondary antibody.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS, 50 % glycerol, 0.09 % sodium azide, Storage buffer may change when conjugated

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: Conjugated antibodies should be stored at 4°C

Détail du antigène

Antigène: Amyloid

Sujet: Amyloid monomeric proteins can sometimes oligomerize into destructive amyloid fibrils. Amyloidogenic conformations of non-disease related proteins can be created by partial protein misfolding or denaturation. Many degenerative diseases are known to be related to the accumulation of misfolded proteins as amyloid fibres (1, 2). These include the amyloid-β peptide plaques and tau neurofibrillary tangles in senile plaques of Alzheimer's symptomology, the deposition of α-synuclein in the Lewy bodies of Parkinson's disease, and accumulation of polyglutamine-containing aggregates in Huntington's disease (2, 3).